Cargando…
TargetMine 2022: a new vision into drug target analysis
SUMMARY: We introduce the newest version of TargetMine, which includes the addition of new visualization options; integration of previously disaggregated functionality; and the migration of the front-end to the newly available Bluegenes service. AVAILABILITY AND IMPLEMENTATION: TargeteMine is access...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477527/ https://www.ncbi.nlm.nih.gov/pubmed/35894632 http://dx.doi.org/10.1093/bioinformatics/btac507 |
_version_ | 1784790380985712640 |
---|---|
author | Chen, Yi-An Allendes Osorio, Rodolfo S Mizuguchi, Kenji |
author_facet | Chen, Yi-An Allendes Osorio, Rodolfo S Mizuguchi, Kenji |
author_sort | Chen, Yi-An |
collection | PubMed |
description | SUMMARY: We introduce the newest version of TargetMine, which includes the addition of new visualization options; integration of previously disaggregated functionality; and the migration of the front-end to the newly available Bluegenes service. AVAILABILITY AND IMPLEMENTATION: TargeteMine is accessible online at https://targetmine.mizuguchilab.org/bluegenes. Users do not need to register to use the software. Source code for the different components listed in the article is available from TargetMine’s organizational account at http://github.com/targetmine. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. |
format | Online Article Text |
id | pubmed-9477527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94775272022-09-19 TargetMine 2022: a new vision into drug target analysis Chen, Yi-An Allendes Osorio, Rodolfo S Mizuguchi, Kenji Bioinformatics Applications Note SUMMARY: We introduce the newest version of TargetMine, which includes the addition of new visualization options; integration of previously disaggregated functionality; and the migration of the front-end to the newly available Bluegenes service. AVAILABILITY AND IMPLEMENTATION: TargeteMine is accessible online at https://targetmine.mizuguchilab.org/bluegenes. Users do not need to register to use the software. Source code for the different components listed in the article is available from TargetMine’s organizational account at http://github.com/targetmine. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Oxford University Press 2022-07-27 /pmc/articles/PMC9477527/ /pubmed/35894632 http://dx.doi.org/10.1093/bioinformatics/btac507 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Applications Note Chen, Yi-An Allendes Osorio, Rodolfo S Mizuguchi, Kenji TargetMine 2022: a new vision into drug target analysis |
title | TargetMine 2022: a new vision into drug target analysis |
title_full | TargetMine 2022: a new vision into drug target analysis |
title_fullStr | TargetMine 2022: a new vision into drug target analysis |
title_full_unstemmed | TargetMine 2022: a new vision into drug target analysis |
title_short | TargetMine 2022: a new vision into drug target analysis |
title_sort | targetmine 2022: a new vision into drug target analysis |
topic | Applications Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477527/ https://www.ncbi.nlm.nih.gov/pubmed/35894632 http://dx.doi.org/10.1093/bioinformatics/btac507 |
work_keys_str_mv | AT chenyian targetmine2022anewvisionintodrugtargetanalysis AT allendesosoriorodolfos targetmine2022anewvisionintodrugtargetanalysis AT mizuguchikenji targetmine2022anewvisionintodrugtargetanalysis |